breast carcinoma cancer
cell ORientation Breast cancer
marketable cell
metastatic grade of breast cancer
common cancer
mammary tumors
EMT state of breast carcinoma cells
marketable assays
EMT process
MATADOR
mammary neoplastic tissues
ERC Frontier Research
metastatic dissemination
MAmmary chemoresistant Tumor deAth
ERC proof
primary tumors
basic research
new cases
discovery of new drugs
key program of molecular events
Thery
genuine innovative strategy
created intellectual property
concept project
Nieto MA
seductive way
diversity of treatment options
CRO-type biotechnology company
availability of diagnosis tools
prognosis
Grant
therapeutics
transcriptomic biomarkers
mesenchymal transition
decade
Burute
preliminary results
year survival rate
Advances
women